Telix Pharmaceuticals Austin, TX acquired QSAM Biosciences, Inc.

Telix Pharmaceuticals Austin, TX -> QSAM Biosciences, Inc. · $33.1 million

We are equally excited for our shareholders, as we believe this is a great outcome for their investments." Dr Christian Behrenbruch, Managing Director and Group CEO of Telix said, "The acquisition of QSAM provides Telix with an additional near-term therapeutic